The Scientist

» industry

Most Recent

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: Addressing Biomedical Science’s PhD Problem

Addressing Biomedical Science’s PhD Problem

By | January 1, 2017

Researchers and institutions seek to bridge the gap between emerging life science professionals and available positions.

7 Comments

image: Industry-Funded Sugar Study: Don’t Trust Other Sugar Studies

Industry-Funded Sugar Study: Don’t Trust Other Sugar Studies

By | December 21, 2016

Two opposing papers in Annals of Internal Medicine battle over dietary guidelines on sugar.

3 Comments

image: 2016 Salary Survey: By the Numbers

2016 Salary Survey: By the Numbers

By | November 1, 2016

This year's life sciences salary survey turned up some interesting trends in the U.S. and around the world.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Thermo Fisher to Acquire FEI

Thermo Fisher to Acquire FEI

By | June 1, 2016

In a $4.2 billion deal, the science equipment giant is buying the Hillsboro, Oregon-based electron microscope maker.

0 Comments

image: Do Patents Promote or Stall Innovation?

Do Patents Promote or Stall Innovation?

By | June 1, 2016

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

3 Comments

image: E.U. Delays Vote on Roundup

E.U. Delays Vote on Roundup

By | May 24, 2016

Newly published research on the key ingredient in the Monsanto-made weed killer is holding up lawmakers’ decisions on whether to continue to allow its sale in Europe.

4 Comments

The US Department of Agriculture orders Santa Cruz Biotechnology to pay a $3.5 million fine and to cease selling research antibodies.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS